USANA outlines 4% sales growth target for 2026 amid omnichannel and product innovation push
2026-02-18 12:56:03 ET
More on USANA Health Sciences
- USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
- USANA Health Sciences: A Turnaround Watch List But Not A Bargain Yet
- USANA Health Sciences Q4 2025 Earnings Preview
- USANA Health expects fiscal 2025 net sales to exceed guidance
- Seeking Alpha’s Quant Rating on USANA Health Sciences
Read the full article on Seeking Alpha
For further details see:
USANA outlines 4% sales growth target for 2026 amid omnichannel and product innovation pushNASDAQ: USNA
USNA Trading
-5.14% G/L:
$17.84 Last:
83,616 Volume:
$17.84 Open:



